Aug. 2 at 10:42 PM
$TMO reading comments, and clearly no one listened to the earnings call. Their existing customers are keeping them in the black. And the push to bring Pharma companies to expand in the USA means more sales incoming. Their partners are already planning. Grabbed a few
$510C into October. I think it retests
$525-535 by September. Not sure if it will hold, but overall it a pretty beaten up stock. And if China deal comes out favorable, this will affect price.
